Dermata Therapeutics, Inc. (DRMA)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Sep 04, 16:00
1.24
+0.03
(+2.48%)
After-Hours: 20:00
Dermata Therapeutics Market Cap : 4.867M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 4.867M |
| September 03, 2026 | 4.947M |
| September 02, 2026 | 5.148M |
| September 01, 2026 | 5.229M |
| August 31, 2026 | 5.188M |
| August 28, 2026 | 5.390M |
| August 27, 2026 | 5.872M |
| August 26, 2026 | 6.476M |
| August 25, 2026 | 6.918M |
| August 24, 2026 | 6.556M |
| August 21, 2026 | 5.711M |
| August 20, 2026 | 5.550M |
| August 19, 2026 | 5.912M |
| August 18, 2026 | 5.752M |
| August 17, 2026 | 5.872M |
| August 14, 2026 | 5.872M |
| August 13, 2026 | 6.315M |
| August 12, 2026 | 5.550M |
| August 11, 2026 | 4.344M |
| August 10, 2026 | 4.505M |
| August 07, 2026 | 4.424M |
| August 06, 2026 | 4.464M |
| August 05, 2026 | 4.706M |
| August 04, 2026 | 4.424M |
| August 03, 2026 | 4.324M |
| Date | Value |
|---|---|
| July 31, 2026 | 4.706M |
| July 30, 2026 | 4.746M |
| July 29, 2026 | 4.746M |
| July 28, 2026 | 4.967M |
| July 27, 2026 | 5.188M |
| July 24, 2026 | 5.309M |
| July 23, 2026 | 5.068M |
| July 22, 2026 | 5.068M |
| July 21, 2026 | 5.148M |
| July 20, 2026 | 5.108M |
| July 17, 2026 | 5.349M |
| July 16, 2026 | 5.148M |
| July 15, 2026 | 5.229M |
| July 14, 2026 | 5.309M |
| July 13, 2026 | 5.430M |
| July 10, 2026 | 5.390M |
| July 09, 2026 | 5.390M |
| July 08, 2026 | 5.631M |
| July 07, 2026 | 5.671M |
| July 06, 2026 | 5.390M |
| July 02, 2026 | 5.390M |
| July 01, 2026 | 5.550M |
| June 30, 2026 | 5.188M |
| June 29, 2026 | 5.229M |
| June 26, 2026 | 5.188M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 278.50M |
| Perspective Therapeutics, Inc. | 357.09M |
| MiMedx Group, Inc. | 665.96M |
| ABVC BioPharma, Inc. | 24.74M |
| Endonovo Therapeutics, Inc. | 0.1808M |
Market Cap Related Metrics
| Price to Book Value | 1.395 |
| Price | 1.21 |
| Earnings Yield | -362.5% |